Resources Library by ANA

Recent prescription and price policy of drugs in The Netherlands

In this presentation we would like to present a survey of recent developments in the drugs market in the Netherlands. We will base ourselves on publications in newspapers and trade magazines and on information published by public bodies in so far as...

Catalogue: Seminar 1987: Pricing And Forecasting In Pharmaceutical Industry

Authors: J. G. J. Huurman, Frits Spangenberg

Company: Motivaction International B.V.

June 15, 1987

Socioeconomic benefits of drugs

As a result socioeconomic differentiation may represent additionally to the drug's therapeutic merit-proof a decisive component to achieve a sustainable competitive edge. It represents a strategic element which pharmaceutical companies will have to...

Catalogue: Seminar 1987: Pricing And Forecasting In Pharmaceutical Industry

Author: J. Wernli

June 15, 1987

Pricing research what should we actually remeasuring?

Pricing research should help companies to calculate the optimum price for each of their products, in order for companies to achieve their basic goal: Profitability. Pricing research however often fails to do this. Indeed, despite the large number of...

Catalogue: Seminar 1987: Pricing And Forecasting In Pharmaceutical Industry

Authors: Martine Leroy-Sharman, Ian Tinn

June 15, 1987

A model for a cost-benefit analysis of a new pharmaceutical

There is growing clamour of late that the evaluation of new pharmaceuticals should not only contain analysis of safety and efficacy, but also elements of economic analysis. The reason: the quality of present-day background material is such that it...

Catalogue: Seminar 1987: Pricing And Forecasting In Pharmaceutical Industry

Author: P. Hertzman

June 15, 1987

The structure of the costs recognized by the price formation method used for medicinal specialties in Italy

Characterisation of the structure of the pharmacy distribution channel of the Italian drug market by means of a large sample (672 different preparations of 497 pharmaceuticals produced by 135 Italian and foreign drug companies). The sample, witch...

Catalogue: Seminar 1987: Pricing And Forecasting In Pharmaceutical Industry

Authors: Paolo Loreti, Mario Racco

June 15, 1987

The use of conjoint analysis in forecasting and price elasticity for a new pharmaceutical entry

This paper presents a quantitative marketing research survey through the use of multivariate techniques to address several pre-launch issues of a new product. The main emphasis in the analysis is the use of the conjoint model to determine the actual...

Catalogue: Seminar 1987: Pricing And Forecasting In Pharmaceutical Industry

Author: Mila C. Montemayor-Orr

June 15, 1987

Potential evolutions of medical, industrial, and distribution practices in the Japanese pharmaceutical business strategy of the Japanese government

Since some years the Japanese government had decided to yearly reduce the drug reimbursement price considerably and to ask patients to share a greater part of the medical cost. The government, thus was working towards at least two goals: - Reduction...

Catalogue: Seminar 1987: Pricing And Forecasting In Pharmaceutical Industry

Author: J. B. Bouée

June 15, 1987

Forecasting new over-the-counter drug sales at various price levels

In this paper, several case examples, including several new self-diagnosed test products are presented. Detailed description of the pre-test market procedure, including the use of either printed concept material or TV commercial with product trial...

Catalogue: Seminar 1987: Pricing And Forecasting In Pharmaceutical Industry

Author: Lynn Y.S. Lin

Company: Burke, Inc.

June 15, 1987

Price sensitivity analysis in the UK pharmaceutical market

The purpose of this paper is to outline the considerations that should be taken into account when choosing the optimum price for a new product in the United Kingdom. The paper will cover three broad areas. Firstly the determination of a target price...

Catalogue: Seminar 1987: Pricing And Forecasting In Pharmaceutical Industry

Authors: Richard Dajda, David Owen

Company: KANTAR TNS Malaysia

June 15, 1987